Episil Holding (3707) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Episil Holding stock TWD 46.77, price TWD 50.90, that is 8.1% below the price, quality 39 out of 100. Rating: fairly valued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range 30.65 TWD – 162.73 TWD · fair‑value band 30.96 TWD – 58.62 TWD · the 50.90 TWD price screens above the 46.77 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 6, 2026.
Follow Episil in your weekly email
Every Wednesday you see whether Episil is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Episil Technologies Inc. provides foundry for linear bipolar IC, and foundry with compound GaN and SiC in Taiwan. It also offers High Power MOSFET, Mix-mode integrated circuit, high voltage CMOS, FRD, TVS, SiC, FRMOS, and GaN discrete device manufacturing services, as well as professional services.
Show moreShow less
The company was formerly known as Episil Holding Inc. Episil Technologies Inc. was founded in 1985 and is headquartered in Hsinchu City, Taiwan.
Stock analysis
Episil Holding (3707) currently trades at 50.90 TWD, while our model-based Fair Value estimate is 46.77 TWD, so the stock looks roughly fairly valued today (gap 8.8%).
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 80/100, which puts the data coverage at low.
Scenario range: 30.96 TWD (bear) to 58.62 TWD (bull), the price of 50.90 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Technology sector.
Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Episil Holding reported revenue of 5.8B TWD in FY2025 versus 7.3B TWD in FY2021, a compound −5.6%/yr. Reported net income was −757M TWD in FY2025.
Key figures
Market cap 27.4B TWD (≈ $835M) Small · P/S ratio 4.25 · EPS (TTM) −1.52 TWD · Net margin −9.2% · Return on equity −4.4% · Return on assets (EBIT) 1.1% (5-year average) · Operating margin 1.1% · Revenue (TTM) 6.4B TWD.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (low confidence).
What moves the price
The share trades about 49% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −7% fair-value upside, at −8%, 3707 screens richer than that median.
Fair Value models
Bear30.96 TWDFair Value 46.77 TWDBull58.62 TWD
Price 50.90 TWD · Downside -8.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
−0.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.1%
Start year 2020 (pandemic). Over 10 years: +6.1% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
’13
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−7.9% (2020) → −15.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductors · 370 stocks
Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score39 · Bottom 25%
Fair Value upside−8.1% · Above median
Profitability
Return on assets−5.9% · Bottom 25%
Net margin (12 months)−9.2% · Bottom 25%
Operating margin (12 months)1.1% · Below median
Growth and dividend
Revenue growth (quarter YoY)29.6% · Above median
Balance sheet
Debt / equity0.16× · Above median
Valuation Multiplesvs Semiconductors median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Episil Holding Fair Value". https://www.fairvalue-calculator.com/stock/3707
Frequently asked questions
Is Episil Holding (3707) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 46.77 TWD versus a price of 50.90 TWD, about 8% lower (fairly valued).
What is the fair value of 3707?
Our model-based fair value for Episil Holding is 46.77 TWD (as of Nov 6, 2026), built from audited fundamentals. The current price: 50.90 TWD.
What is the quality score of 3707?
Episil Holding has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Episil Holding (3707)?
Our model-based price target is the fair value of 46.77 TWD (as of Nov 6, 2026) from 1 valuation models. Cautious scenario 30.96 TWD, optimistic scenario 58.62 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Episil Holding stock forecast for 2026?
Our models put fair value at 46.77 TWD, about 8% lower versus a price of 50.90 TWD (fairly valued). Cautious scenario 30.96 TWD, optimistic scenario 58.62 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Episil Holding (3707)?
Episil Holding reported trailing-twelve-month revenue of about 6.4B TWD (latest available figure, as of Nov 6, 2026).
What is the intrinsic value of Episil Holding (3707)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Episil Holding it is 46.77 TWD per share (as of Nov 6, 2026), against a price of 50.90 TWD. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Episil Holding stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 3707 trades above its calculated fair value: price 50.90 TWD, fair value 46.77 TWD, a gap of about −8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3707?
No. The price is what the market pays today (50.90 TWD); the fair value is what the company's own numbers justify (46.77 TWD). For Episil Holding the two are 4.13 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Episil Holding worth?
The market values Episil Holding at about 27.4B TWD (market capitalisation, as of Nov 6, 2026). Per share that is 50.90 TWD; our models calculate a fair value of 46.77 TWD per share.
What do the bullish and bearish scenarios say about 3707?
Our models span a range for Episil Holding: cautious scenario 30.96 TWD, base 46.77 TWD, optimistic 58.62 TWD per share (as of Nov 6, 2026, price 50.90 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Episil Holding (3707)?
Balance-sheet figures for Episil Holding (as of Nov 6, 2026): return on equity −4.4%, debt of 0.16 per unit of equity. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is 3707 from its 52-week high?
Episil Holding trades at 50.90 TWD, about 49% below its 52-week high of 100.50 TWD and 12% above the low of 45.60 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 46.77 TWD is for.
Which stocks are comparable to Episil Holding?
From the same area (Technology) we also value NVIDIA Corporation, Taiwan Semiconductor Manufacturing Company, Broadcom Inc, Micron Technology, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Episil Holding stock attractive at the current price?
The data as of Nov 6, 2026: price 50.90 TWD, calculated fair value 46.77 TWD (−8%), Quality Score 39/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3707 calculated?
We run Episil Holding through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of 46.77 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Episil Holding itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Episil Holding (3707)?
The closing price on Nov 6, 2026 was 50.90 TWD. Our model-based fair value is 46.77 TWD, about 8% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Episil Holding right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (30.96 TWD to 58.62 TWD) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Episil Holding
How large is the market capitalisation of Episil Holding (3707)?
The market capitalisation of Episil Holding is 27.4B TWD (≈ $835M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Episil Holding (3707)?
The price-to-sales ratio of Episil Holding is 4.25 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Episil Holding (3707)?
Earnings per share at Episil Holding are −1.52 TWD. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Episil Holding (3707)?
The net margin of Episil Holding is −9.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Episil Holding (3707)?
The return on equity (ROE) of Episil Holding is −4.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Episil Holding (3707)?
On an EBIT basis the return on assets of Episil Holding is 1.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Episil Holding (3707)?
The operating margin of Episil Holding is 1.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Episil Holding (3707)?
Revenue at Episil Holding is growing +29.6% versus a year earlier (3y avg −13.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Episil Holding (3707)?
Earnings per share at Episil Holding are growing −98.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Episil Holding (3707) generate?
The free cash flow of Episil Holding is −1.6B TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Episil Holding (3707) hold?
Episil Holding holds more cash than debt, 1.2B TWD net (fiscal year 2023). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Episil Holding in the live analysis
One click puts Episil Holding on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 6, 2026